Clinical Potential of Genetically Modified Antibodies
Verified
Added on 2022/12/05
|8
|2082
|324
AI Summary
Using genetically modified antibodies, accounting the sensitivity of the patient could optimize the outcome of the medication. Genetically engineered monoclonal antibodies are prescribed worldwide for treating variety of cancers, autoimmune disorders and inflammatory diseases.
Contribute Materials
Your contribution can guide someone’s learning journey. Share your
documents today.